During the current pandemic, the importance of continually monitoring viral genomes for new mutations has become fundamental to help guide…

It’s already happened: Several SARS-CoV-2 variants are upon us, lurking in various populations, bringing more uncertainty about how this pandemic…

How integrative analysis of multi-omics data accelerates biomarker and target discovery in inherited disease The analysis of multi-omics data has enabled unprecedented advances in discovering biomarkers…

Whole-exome sequencing (WES) using next-generation sequencing (NGS) technology is a powerful tool for investigating variants linked to genetic disease. It…

Next-generation sequencing (NGS) techniques allow high-throughput detection of a vast amount of genetic variations in a cost-effective manner. However, there…

Hint: The secret is in the biological context Today’s discovery scientists are challenged with identifying new biomarkers and therapeutic targets…

Read about how researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in a variety…

Discover our new platform for exploring highly curated single-cell RNA-seq data  Are you looking for highly curated single-cell (scRNA-seq) data…

The Winter 2020 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the world’s largest collection of…

Read about how researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in a variety…

Discover more about the latest QCI features and how the platform simplifies and accelerates NGS variant analysis, interpretation, and reporting…

Check out the new features of QIAGEN CLC Genomics  Are you struggling to find a bioinformatics analysis tool that meets…